img

Global Chickenpox Vaccine Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Chickenpox Vaccine Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Chickenpox Vaccine market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Chickenpox Vaccine market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Chickenpox Vaccine in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Monovalent Vaccine
Combination Vaccine

Market Snapshot, By Application
Kids Injection
Adults Injection

Main Market Players Analyzed in this report, including
Shanghai Institute
Merck
Keygen
GSK
Green Cross
Changsheng
Biken
BCHT

The study objectives of this report are
To study and analyze the global Chickenpox Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Chickenpox Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Chickenpox Vaccine manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chickenpox Vaccine market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Chickenpox Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Chickenpox Vaccine are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Chickenpox Vaccine Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Chickenpox Vaccine Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Chickenpox Vaccine

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Chickenpox Vaccine Sales Channel and Distributors Analysis
3.3.1 Chickenpox Vaccine Sales Channel
3.3.2 Chickenpox Vaccine Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Kids Injection
3.4.2 Major Buyers in Adults Injection
3.5 Chickenpox Vaccine Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Chickenpox Vaccine Type Introduction
4.1.1 Monovalent Vaccine
4.1.2 Combination Vaccine
4.2 Global Chickenpox Vaccine Sales by Type 2016-2021
4.3 Global Chickenpox Vaccine Revenue by Type 2016-2021
4.4 Global Chickenpox Vaccine Price by Type 2016-2021

5 Market Segment: by Application
5.1 Chickenpox Vaccine Type Introduction
5.1.1 Kids Injection
5.1.2 Adults Injection
5.2 Global Chickenpox Vaccine Sales by Application 2016-2021
5.3 Global Chickenpox Vaccine Revenue by Application 2016-2021
5.4 Global Chickenpox Vaccine Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Chickenpox Vaccine Market by Region
6.1.1 Global Chickenpox Vaccine Sales by Regions
6.1.2 Global Chickenpox Vaccine Revenue by Regions
6.2 North America Chickenpox Vaccine Market 2016-2021
6.3 Europe Chickenpox Vaccine Market 2016-2021
6.4 Asia Pacific Chickenpox Vaccine Market 2016-2021
6.5 South America Chickenpox Vaccine Market 2016-2021
6.6 Middle East and Africa Chickenpox Vaccine Market 2016-2021

7 North America
7.1 North America Chickenpox Vaccine Market by Country 2016-2021
7.1.1 North America Chickenpox Vaccine Sales by Country
7.1.2 North America Chickenpox Vaccine Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Chickenpox Vaccine Market by Country 2016-2021
8.1.1 Europe Chickenpox Vaccine Sales by Country
8.1.2 Europe Chickenpox Vaccine Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Chickenpox Vaccine Market by Country 2016-2021
9.1.1 Asia Pacific Chickenpox Vaccine Sales by Country
9.1.2 Asia Pacific Chickenpox Vaccine Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Chickenpox Vaccine Market by Country 2016-2021
10.1.1 South America Chickenpox Vaccine Sales by Country
10.1.2 South America Chickenpox Vaccine Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Chickenpox Vaccine Market by Country 2016-2021
11.1.1 Middle East and Africa Chickenpox Vaccine Sales by Country
11.1.2 Middle East and Africa Chickenpox Vaccine Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Shanghai Institute
12.1.1 Shanghai Institute Company Information
12.1.2 Shanghai Institute Chickenpox Vaccine Product Portfolio, Specification and Application
12.1.3 Shanghai Institute Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Shanghai Institute Key Development
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Chickenpox Vaccine Product Portfolio, Specification and Application
12.2.3 Merck Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Merck Key Development
12.3 Keygen
12.3.1 Keygen Company Information
12.3.2 Keygen Chickenpox Vaccine Product Portfolio, Specification and Application
12.3.3 Keygen Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Keygen Key Development
12.4 GSK
12.4.1 GSK Company Information
12.4.2 GSK Chickenpox Vaccine Product Portfolio, Specification and Application
12.4.3 GSK Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 GSK Key Development
12.5 Green Cross
12.5.1 Green Cross Company Information
12.5.2 Green Cross Chickenpox Vaccine Product Portfolio, Specification and Application
12.5.3 Green Cross Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Green Cross Key Development
12.6 Changsheng
12.6.1 Changsheng Company Information
12.6.2 Changsheng Chickenpox Vaccine Product Portfolio, Specification and Application
12.6.3 Changsheng Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Changsheng Key Development
12.7 Biken
12.7.1 Biken Company Information
12.7.2 Biken Chickenpox Vaccine Product Portfolio, Specification and Application
12.7.3 Biken Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Changsheng Key Development
12.8.1 BCHT Company Information
12.8.2 BCHT Chickenpox Vaccine Product Portfolio, Specification and Application
12.8.3 BCHT Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 BCHT Key Development

13 Global Chickenpox Vaccine Market Forecast by Region by Type and by Application
13.1 Global Chickenpox Vaccine Sales, Revenue Forecast 2022-2027
13.2 Global Chickenpox Vaccine Forecast by Regions
13.2.1 Global Chickenpox Vaccine Sales Forecast by Region 2022-2027
13.2.2 Global Chickenpox Vaccine Revenue Forecast by Region 2022-2027
13.3 Global Chickenpox Vaccine Forecast by Type
13.3.1 Global Chickenpox Vaccine Sales Forecast by Type 2022-2027
13.3.2 Global Chickenpox Vaccine Revenue Forecast by Type 2022-2027
13.3.3 Global Chickenpox Vaccine Price Forecast by Type 2022-2027
13.4 Global Chickenpox Vaccine Forecast by Application
13.4.1 Global Chickenpox Vaccine Sales Forecast by Application 2022-2027
13.4.2 Global Chickenpox Vaccine Revenue Forecast by Application 2022-2027
13.4.3 Global Chickenpox Vaccine Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Chickenpox Vaccine Production Specifications
Table 2: Drivers in Chickenpox Vaccine Market
Table 3: Restraints Chickenpox Vaccine Market
Table 4: Opportunity in Chickenpox Vaccine Market
Table 5: Comparion of Alternative and Chickenpox Vaccine
Table 6: Chickenpox Vaccine Raw Materials Key Suppliers List
Table 7: Chickenpox Vaccine Distributors List
Table 8: Chickenpox Vaccine Major Buyers in Kids Injection
Table 9: Chickenpox Vaccine Major Buyers in Adults Injection
Table 10: Chickenpox Vaccine Major Buyers in
Table 11: Global Chickenpox Vaccine Sales (K Units) by Type 2016-2021
Table 12: Global Chickenpox Vaccine Sales Market Share by Type 2016-2021
Table 13: Global Chickenpox Vaccine Revenue (Million USD) by Type 2016-2021
Table 14: Global Chickenpox Vaccine Revenue Market Share by Type 2016-2021
Table 15: Global Chickenpox Vaccine Price by Type 2016-2021
Table 16: Global Chickenpox Vaccine Sales (K Units) by Application 2016-2021
Table 17: Global Chickenpox Vaccine Sales Market Share by Application 2016-2021
Table 18: Global Chickenpox Vaccine Revenue (Million USD) by Application 2016-2021
Table 19: Global Chickenpox Vaccine Revenue Market Share by Application 2016-2021
Table 20: Global Chickenpox Vaccine Price by Application 2016-2021
Table 21: Global Chickenpox Vaccine Sales (K Units) by Region 2016-2021
Table 22: Global Chickenpox Vaccine Sales Market Share by Region 2016-2021
Table 23: Global Chickenpox Vaccine Revenue (Million USD) by Region 2016-2021
Table 24: Global Chickenpox Vaccine Revenue Market Share by Region 2016-2021
Table 25: North America Chickenpox Vaccine Sales (K Units) by Country 2016-2021
Table 26: North America Chickenpox Vaccine Sales Market Share by Country 2016-2021
Table 27: North America Chickenpox Vaccine Revenue (Million USD) by Country 2016-2021
Table 28: North America Chickenpox Vaccine Revenue Market Share by Country 2016-2021)
Table 29: Europe Chickenpox Vaccine Sales (K Units) by Country 2016-2021
Table 30: Europe Chickenpox Vaccine Sales Market Share by Country 2016-2021
Table 31: Europe Chickenpox Vaccine Revenue (Million USD) by Country 2016-2021
Table 32: Europe Chickenpox Vaccine Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Chickenpox Vaccine Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Chickenpox Vaccine Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Chickenpox Vaccine Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Chickenpox Vaccine Revenue Market Share by Country 2016-2021)
Table 37: South America Chickenpox Vaccine Sales (K Units) by Country 2016-2021
Table 38: South America Chickenpox Vaccine Sales Market Share by Country 2016-2021
Table 39: South America Chickenpox Vaccine Revenue (Million USD) by Country 2016-2021
Table 40: South America Chickenpox Vaccine Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Chickenpox Vaccine Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Chickenpox Vaccine Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Chickenpox Vaccine Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Chickenpox Vaccine Revenue Market Share by Country 2016-2021)
Table 45 Shanghai Institute Company Information
Table 46 Shanghai Institute Chickenpox Vaccine Product Portfolio, Specification and Application
Table 47 Shanghai Institute Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Merck Company Information
Table 49 Merck Chickenpox Vaccine Product Portfolio, Specification and Application
Table 50 Merck Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Keygen Company Information
Table 52 Keygen Chickenpox Vaccine Product Portfolio, Specification and Application
Table 53 Keygen Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 GSK Company Information
Table 55 GSK Chickenpox Vaccine Product Portfolio, Specification and Application
Table 56 GSK Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Green Cross Company Information
Table 58 Green Cross Chickenpox Vaccine Product Portfolio, Specification and Application
Table 59 Green Cross Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Changsheng Company Information
Table 61 Changsheng Chickenpox Vaccine Product Portfolio, Specification and Application
Table 62 Changsheng Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Biken Company Information
Table 64 Biken Chickenpox Vaccine Product Portfolio, Specification and Application
Table 65 Biken Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 BCHT Company Information
Table 67 BCHT Chickenpox Vaccine Product Portfolio, Specification and Application
Table 68 BCHT Chickenpox Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Chickenpox Vaccine Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Chickenpox Vaccine Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Chickenpox Vaccine Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Chickenpox Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Chickenpox Vaccine Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Chickenpox Vaccine Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Chickenpox Vaccine Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Chickenpox Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Chickenpox Vaccine Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Chickenpox Vaccine Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Chickenpox Vaccine Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Chickenpox Vaccine Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Chickenpox Vaccine Picture
Figure 2: Global Chickenpox Vaccine Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Chickenpox Vaccine Supply Chain Analysis
Figure 5: Chickenpox Vaccine Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Monovalent Vaccine
Figure 7: Product Picture of Combination Vaccine
Figure 8: Global Chickenpox Vaccine Sales Market Share by Type, 2020
Figure 9: Global Chickenpox Vaccine Revenue Market Share by Type, 2020
Figure 10: Chickenpox Vaccine in Kids Injection
Figure 11: Global Chickenpox Vaccine Market: Kids Injection 2016-2021
Figure 12: Chickenpox Vaccine in Adults Injection
Figure 13: Global Chickenpox Vaccine Market: Adults Injection 2016-2021
Figure 14: Global Chickenpox Vaccine Sales Market Share by Application, 2020
Figure 15: Global Chickenpox Vaccine Revenue Market Share by Application, 2020
Figure 16: Global Chickenpox Vaccine Sales Market Share by Region 2016-2021
Figure 17: Global Chickenpox Vaccine Revenue Market Share by Region 2016-2021
Figure 18: North America Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 19: North America Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 20: Europe Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 21: Europe Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 24: South America Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 25: South America Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 28: North America Chickenpox Vaccine Sales Market Share by Country, 2020
Figure 29: North America Chickenpox Vaccine Revenue Market Share by Country, 2020
Figure 30: United States Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 31: United States Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 32: Canada Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 33: Canada Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 35: Mexico Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 36: Europe Chickenpox Vaccine Sales Market Share by Country, 2020
Figure 37: Europe Chickenpox Vaccine Revenue Market Share by Country, 2020
Figure 38: Germany Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 39: Germany Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 40: France Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 41: France Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 42: UK Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 43: UK Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 44: Italy Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 45: Italy Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 46: Russia Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 46: Russia Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 47: Spain Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 48: Spain Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Chickenpox Vaccine Sales Market Share by Country, 2020
Figure 50: Asia Pacific Chickenpox Vaccine Revenue Market Share by Country, 2020
Figure 51: China Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 52: China Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 53: Japan Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 54: Japan Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 55: Korea Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 56: Korea Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 59: India Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 60: India Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 61: Australia Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 62: Australia Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 63: South America Chickenpox Vaccine Sales Market Share by Country, 2020
Figure 64: South America Chickenpox Vaccine Revenue Market Share by Country, 2020
Figure 65: Brazil Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 66: Brazil Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 68: Argentina Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 70: Colombia Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Chickenpox Vaccine Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Chickenpox Vaccine Revenue Market Share by Country, 2020
Figure 73: Turkey Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 74: Turkey Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Chickenpox Vaccine Sales (K Units) Status 2016-2021
Figure 78: South Africa Chickenpox Vaccine Revenue (Million USD) Status 2016-2021
Figure 79: Shanghai Institute Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 80: Merck Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 81: Keygen Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 82: GSK Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 83: Green Cross Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 84: Changsheng Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 85: Biken Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 86: BCHT Chickenpox Vaccine Revenue Market Share Globally (2019-2021)
Figure 89: Global Chickenpox Vaccine Sales (K Units) Forecast (2022-2027)
Figure 90: Global Chickenpox Vaccine Sales (K Units) Forecast (2022-2027)